Novel ghrelin inverse agonist as therapeutic candidate against obesity-related metabolic diseases Jan. 25, 2019
Patient enrollment ongoing in phase II study of CFI-400945 in advanced/metastatic breast cancer Jan. 25, 2019
FDA places partial clinical hold on phase III study of axalimogene filolisbac in cervical cancer Jan. 24, 2019
RSS